ReviewPatient preference and adherence2014
Subcutaneous bortezomib for multiple myeloma treatment: patients' benefits.
Maria Teresa Petrucci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it